Ten stocks kicked off the trading week with significant gains, mirroring Wall Street’s broader optimism, as investors cheered strong US jobs data while waiting on the sidelines for developments on the US’ war on Iran.
On Wall Street, all three major indices finished in the green, led by the Nasdaq, up 0.54 percent, followed by the S&P 500, jumping 0.44 percent, and the Dow Jones, increasing 0.36 percent.
Indices aside, we spotlight the 10 top-performing companies on Monday and detail the reasons behind their gains.
To come up with the list, we focused on the stocks with a $2 billion market capitalization and 5 million shares in trading volume.
Photo by Tima Miroshnichenko on Pexels
10. Bitmine Immersion Technologies Inc. (NYSE:BMNR)
Bitmine Immersion jumped by 5.91 percent on Monday to close at $20.60 apiece after boosting its Ethereum ownership to more than 4.8 million and successfully switching its trading of shares to the largest Exchange in the US.
In terms of acquisition, Bitmine Immersion Technologies Inc. (NYSE:BMNR) said that it accelerated its Ethereum purchase last week to 71,252 ETH, which is the highest pace of buys since the week of December 22. It now holds a total of 4,803,334 ETH.
Of the said holdings, some $7.1 billion of ETH have been staked, covering 3,334,637 ETH, and generated annual revenues of $196 million.
Bitmine Immersion Technologies Inc. (NYSE:BMNR) noted that ETH remains the second best-performing asset despite the ongoing trade tensions in the Middle East, having gained 6.8 percent and outperforming the S&P 500 and gold by 1,130 basis points (bp) and 1,840 bp, respectively.
“The war has placed downward pressure on global markets, so it is impressive to see ETH as one of the few to rise on an absolute basis. This is a great harbinger, as we expect ETH leadership to strengthen investors and eventually take cash off the sidelines,” Lee noted.
“Ethereum continues to benefit from the dual tailwinds of Wall Street tokenizing on the blockchain and from agentic AI systems increasingly needing public and neutral blockchains,” he added.
Meanwhile, Bitmine Immersion Technologies Inc. (NYSE:BMNR) officially joined the roster of NYSE-listed companies on the same day, transitioning from the NYSE American. The switch opened doors for higher exposure to international and institutional investors.
9. Celsius Holdings Inc. (NASDAQ:CELH)
Celsius snapped a two-day losing streak on Monday, surging 6.02 percent to close at $36.13 apiece, as investors hunted for bargains after the company fell to an 11-month low last Friday.
Year-to-date, Celsius Holdings Inc. (NASDAQ:CELH) has already lost as much as 27.6 percent, while in March alone, its shares fell by as much as 38 percent.
The rally, however, can be attributed to analyst optimism, with Deutsche Bank last week upgrading its recommendation to “buy” from “hold,” while raising its price target by 27 percent to $56 from $44 previously.
As of its latest closing price, the price target marked a 55 percent upside potential.
Deutsche Bank said that its optimism for Celsius Holdings Inc. (NASDAQ:CELH) to generate top-tier growth in revenues and EBITDA despite weaker convenience store traffic trends, competition challenges, and adverse aluminum and freight costs.
It noted that it expects the company to benefit from a more measured innovation calendar to support revenue resilience, and that it holds several margin expansion levers, including PepsiCo’s direct store delivery network, which should protect its profitability.
Last year, Celsius Holdings Inc. (NASDAQ:CELH) dropped its net income attributable to shareholders by 40 percent last year to $63.8 million from $107.4 million in 2024. Revenues, however, soared by 92 percent to $2.5 billion from $1.3 billion year-on-year.
8. Hims & Hers Health Inc. (NYSE:HIMS)
Hims & Hers bounced back by 6.22 percent on Monday to close at $20.33 apiece, as investors positioned their second-quarter portfolios backed by optimism over its rekindled partnership with Novo Nordisk to jointly capitalize on the $200 billion obesity treatment market.
Late last month, Hims & Hers Health Inc. (NYSE:HIMS) announced that Novo Nordisk’s blockbuster drugs, Wegovy and Ozempic, are now back on its platform.
Eligible customers seeking to purchase the said treatments can avail both pill and injectable versions of Wegovy, except for the 7.2 mg injection, which has yet to be launched. Ozempic injectable pens are also available across all dosages.
“As the largest global consumer health platform, we’re thrilled to be working alongside Novo Nordisk to help more people feel their best and we’re excited to find more ways to collaborate across the industry,” said Hims & Hers Health Inc. (NYSE:HIMS) CEO Andrew Dudum.
For his part, Hims & Hers Health Inc. (NYSE:HIMS) SVP for Weight Management Craig Primack noted that obesity medications have evolved over the last several years to become more affordable, more flexible, and more approachable for every kind of patient.
“As a part of our comprehensive treatment program, these FDA-approved medications will help more people get and stay healthy. We’re excited to see how our customers succeed as more innovative treatments become available,” he noted.
In a study published in February this year, JPMorgan said that it expects the global incretin market to soar to as much as $200 billion over the next four years, thanks to reduced prices and continued strong demand for weight loss treatments.
It noted that the number of Americans alone adopting the treatment is projected to soar by 150 percent by 2030 to 25 million from 10 million previously.
7. Babcock & Wilcox Enterprises Inc. (NYSE:BW)
Babcock & Wilcox soared to a new seven-year high on Monday, as investors poured funds back into companies riding the artificial intelligence boom, supported by optimism following the looming start of development of its $2.4-billion power generation project.
It can be recalled that Babcock & Wilcox Enterprises Inc. (NYSE:BW) earlier secured the green light for the construction of a 1.2-gigawatt power generation project for Base Electron to support the needs of data center giant, Applied Digital Corp.
Under the agreement, Babcock & Wilcox Enterprises Inc. (NYSE:BW) would engineer, procure, and construct four 300-MW natural gas-fired boilers and steam turbine generator systems, with engineering and manufacturing activities already underway. It tapped Siemens Energy, Inc. to design and supply the steam turbine generator sets.
“With data processing demand growing at an unprecedented pace, B&W is uniquely positioned to provide the proven, flexible and redundant power solutions these mission‑critical operations require and deploy them faster than traditional combined-cycle or simple-cycle gas technologies,” Babcock & Wilcox Enterprises Inc. (NYSE:BW) Chairman and CEO Kenneth Young said.
In other news, the company narrowed its net loss attributable to shareholders last year by 39 percent to $36.2 million from $59.9 million in 2024. Total revenues inched up by 1.1 percent to $587.7 million from $581 million year-on-year.
6. Strategy Inc. (NASDAQ:MSTR)
Strategy bounced back by 6.56 percent on Monday to finish at $127.69 apiece, as investors mirrored a broader market optimism following strong US jobs data, while waiting on the sidelines ahead of developments on the Iran war.
The company rallied alongside its counterparts, namely Riot Platforms, MARA Holdings, and CleanSpark Inc., among others, as US indexes clocked gains during the day, thanks to better-than-expected jobs data in the US that overshadowed Strategy Inc.’s (NASDAQ:MSTR) unrealized losses of $14.5 billion in the first quarter of the year, due to Bitcoin’s steep fall during the period.
Year-to-date, the prices of Bitcoin have already gone down by 21.3 percent from $87,503.83.
In other news, Strategy Inc. (NASDAQ:MSTR) last year widened its net loss attributable to shareholders by 259 percent to $4.2 billion from $1.167 billion in 2024. Total revenues inched up by 3 percent to $477 million from $463 million year-on-year.
In the fourth quarter alone, net loss attributable to shareholders soared further by 1,781 percent to $12.6 billion from $670.8 million, while total revenues inched up by 1.9 percent to $122.99 million from $120.7 million year-on-year.
While we acknowledge the potential of MSTR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MSTR and that has 100x upside potential, check out our report about the cheapest AI stock.
Click to continue reading and see the other 5 Stocks With Unexpected Gains.
Disclosure: None. Follow Insider Monkey on Google News.
